SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-24-004321
Filing Date
2024-01-29
Accepted
2024-01-29 17:06:26
Documents
18
Period of Report
2024-01-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20020073_8k.htm   iXBRL 8-K 45168
2 EXHIBIT 99.1 ef20020073_ex99-1.htm EX-99.1 12898
3 EXHIBIT 99.2 ef20020073_ex99-2.htm EX-99.2 26112
7 image00001.jpg GRAPHIC 4014
8 image00003.jpg GRAPHIC 44334
  Complete submission text file 0001140361-24-004321.txt   306799

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA imcr-20240129.xsd EX-101.SCH 3875
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE imcr-20240129_lab.xml EX-101.LAB 22547
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imcr-20240129_pre.xml EX-101.PRE 16051
20 EXTRACTED XBRL INSTANCE DOCUMENT ef20020073_8k_htm.xml XML 4251
Mailing Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY
Business Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY 01235 5430281
Immunocore Holdings plc (Filer) CIK: 0001671927 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39992 | Film No.: 24574543
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)